Company Storing Umbilical Cord Blood for Transplants Sees Enormous Growth

Bioethics   |   Steven Ertelt   |   Mar 19, 2007   |   9:00AM   |   WASHINGTON, DC

Company Storing Umbilical Cord Blood for Transplants Sees Enormous Growth

Email this article
Printer friendly page

by Steven Ertelt
LifeNews.com Editor
March 19
, 2007

Altamonte Springs, FL (LifeNews.com) — A company that processes and stores umbilical cord blood for future medical use says its experiencing significant growth in the amount of cord blood it has on hand. That after Congress and state legislatures have approved bills to promote awareness of using the embryonic stem cell research alternative.

Cryobanks International’s mission is to become the largest provider of cord blood stem cells for transplant and research purposes in the world and it’s well on its way to fulfilling that goal.

With over 15,000 cord blood units processed and 9,000 listed on international registries for transplant, Cryobanks continues its push to help close the gap between patient needs and available resources of donated cord blood.

In recent years, cord blood transplants have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant

According to Cryobanks’ CEO, Dwight Brunoehler, over 35,000 American children and adults with life-threatening illnesses find themselves in need of a transplant each year. More than 150,000 people worldwide could be helped by cord blood transplants.

In a statement LifeNews.com received, Brunoehler said the company is committed to trying to use all cord blood it receives, including the 80% of donated units that do not meet the rigid transplant standards.

He said a variety of reasons including low volume, low viability, incomplete paperwork and positive bacterial fungal culturing can restrict the use of the cord blood for transplant.

In those cases, units that are not acceptable for transplant may be used to advance research in the field. The Florida company furnishes cord blood research units to qualified institutions as long as they are used for non-controversial and non-cosmetic purposes.

When it receives cord blood, the units are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use.

Related web sites:
Cryobanks International – https://w.cryo-intl.com